Concur. I think they are trying to build credibility in using that method as a valid datapoint. Seems there is much scepticism out there that it translates to real world (i.e. blinded vs placebo).
Ann: PharmAust's Phase 1 Study Data Presented at Major Conference, page-22
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.5¢ | 20.5¢ | $34.35K | 163.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 78926 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 268163 | 3 |
View Market Depth
| Last trade - 12.27pm 24/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |